Key Highlights
•
A novel eye-tracking test outperformed standard blood tests for detecting cognitive impairment, achieving an accuracy of 86.5% compared to 69.9-82.6% for plasma biomarkers. This provides a simple, non-invasive digital tool that could revolutionize early screening for Alzheimer’s and other cognitive disorders.
Source →
•
A new machine learning tool that analyzes the ratio of kappa to lambda proteins in blood cells significantly improves the detection of B-cell lymphomas. This approach makes diagnosing this cancer faster, more objective, and less prone to human error, potentially leading to earlier treatment.
Source →
•
A study of over 40,000 patients found that prescribing bone-protecting drugs to people with polymyalgia rheumatica who are on long-term steroids prevents about one fracture for every 109 people treated. This confirms a simple, effective strategy to reduce a major side effect of a common treatment.
Source →
•
A rare but severe case showed that a toxic compound from unripe ackee fruit can pass through breast milk, causing life-threatening metabolic crisis in an infant with a specific genetic vulnerability. This highlights a critical, previously overlooked risk for breastfeeding mothers and the need for clear dietary warnings.
Source →
•
Research using Medicare data revealed that Black patients and those with lower socioeconomic status were significantly less likely to be prescribed newer diabetes drugs like semaglutide and tirzepatide. This points to a serious equity gap in access to the latest and most effective treatments for a widespread chronic disease.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
